Vivo Capital is a private equity firm and venture capital firm. Team members are concentrated in Palo Alto, California, United States. Known portfolio companies include Candid Therapeutics, Achieve Life Science, Immunic Therapeutics, Kinaset Therapeutics, OnKure Therapeutics and ALX Oncology, 10 companies in all.
Is Vivo Capital a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Who to pitch at Vivo Capital
Vivo Capital portfolio companies (10)
- Candid Therapeutics
- Achieve Life Science
- Immunic Therapeutics
- Kinaset Therapeutics
- OnKure Therapeutics
- ALX Oncology
- Sensei Biotherapeutics
- Diamyd Medical
- Oricell Therapeutics
- AN2 Therapeutics
Co-investors
Funds that share portfolio companies with Vivo Capital.
Similar funds
Showing 20 of 100
About Vivo Capital
The firm's listing covers sector Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Life Science; known deals cluster at Late-Stage, Seed and Series B.
The team counts 10 people in our database. Jack Bech Nielsen (Managing Partner), Michael Chang (Managing Partner) and Shan Fu (Managing Partner) are shown as the contacts to pitch.
Vivo Capital shares portfolio companies with 20 other investment firms, among them venBio, TCGX and Marshall Wace.
Frequently asked questions
What is Vivo Capital?
Vivo Capital is a private equity firm and venture capital firm whose team is concentrated in Palo Alto, California, United States, with a known portfolio of 10 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Vivo Capital invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Life Science. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Vivo Capital invest at?
The known deals of Vivo Capital include Late-Stage, Seed and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Vivo Capital?
3 of the 10 people on file at Vivo Capital are listed as contacts for the firm. All 10 have their own profile page.
How do I contact Vivo Capital?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 10 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal